Evidence map›Paper›PMID 33138184›Full record

ArticleCancers2020

Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts.

Ji Wang, Frank H C Cheng, Jessica Tedrow, Wennan Chang, Chi Zhang, Anirban K Mitra

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. TBC1D2 Promotes Ovarian Cancer MetastasisFrontiers in oncology · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ji WangIndiana University School of Medicine-Bloomington, Indiana University, Bloomington, IN 47405, USA.ORCID 0000-0003-3443-5857
Frank H C ChengIndiana University School of Medicine-Bloomington, Indiana University, Bloomington, IN 47405, USA.ORCID 0000-0001-5867-5754
Jessica TedrowIndiana University School of Medicine-Bloomington, Indiana University, Bloomington, IN 47405, USA.ORCID 0000-0002-8584-7651
Wennan ChangMedical and Molecular Genetics Department, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-8113-8252
Chi ZhangMedical and Molecular Genetics Department, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Anirban K MitraIndiana University School of Medicine-Bloomington, Indiana University, Bloomington, IN 47405, USA.
Indiana University Bloomington · USIndiana University Health · USIndiana University School of MedicinePurdue University West Lafayette · US

Funding

NIH HHS 1R01GM131399- 01U.S. Department of Defense W81XWH-15-0253
6 · The paper itself

Abstract

Tumor immune infiltration plays a key role in the progression of solid tumors, including ovarian cancer, and immunotherapies are rapidly emerging as effective treatment modalities. However, the role of cancer-associated fibroblasts (CAFs), a predominant stromal constituent, in determining the tumor-immune microenvironment and modulating efficacy of immunotherapies remains poorly understood. We have conducted an extensive bioinformatic analysis of our and other publicly available ovarian cancer datasets (GSE137237, GSE132289 and GSE71340), to determine the correlation of fibroblast subtypes within the tumor microenvironment (TME) with the characteristics of tumor-immune infiltration. We identified (1) four functional modules of CAFs in ovarian cancer that are associated with the TME and metastasis of ovarian cancer, (2) immune-suppressive function of the collagen 1,3,5-expressing CAFs in primary ovarian cancer and omental metastases, and (3) consistent positive correlations between the functional modules of CAFs with anti-immune response genes and negative correlation with pro-immune response genes. Our study identifies a specific fibroblast subtype, fibroblast functional module (FFM)2, in the ovarian cancer tumor microenvironment that can potentially modulate a tumor-promoting immune microenvironment, which may be detrimental toward the effectiveness of ovarian cancer immunotherapies.

Indexed as

cancer-associated fibroblastsimmune cellsimmunotherapymetastasisovarian cancertumor microenvironment

Identifiers

PMID33138184
PMCPMC7692816
OpenAlexW3096600782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.